Prioritization of the introduction of new vaccines to the national immunization program in the Republic of Korea
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Choe, Young June | - |
dc.contributor.author | Han, Ok Pil | - |
dc.contributor.author | Cho, Heeyeon | - |
dc.contributor.author | Bae, Geun-Ryang | - |
dc.contributor.author | Chun, Byung-Chul | - |
dc.contributor.author | Kim, Jong-Hyun | - |
dc.contributor.author | Kim, Kyung-Hyo | - |
dc.contributor.author | Lee, Hoan Jong | - |
dc.contributor.author | Choi, Eun Hwa | - |
dc.date.accessioned | 2021-09-05T03:56:12Z | - |
dc.date.available | 2021-09-05T03:56:12Z | - |
dc.date.created | 2021-06-15 | - |
dc.date.issued | 2014-10-21 | - |
dc.identifier.issn | 0264-410X | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/97070 | - |
dc.description.abstract | Background: This study was performed to determine the priority of vaccine introduction for five vaccine-preventable diseases (VPDs) caused by Haemophilus influenzae type b (Hib), pneumococcus (Spn), hepatitis A virus (HepA), rotavirus (RV), and human papillomavirus (HPV) to the future Korean National Immunization Program (NIP) and to suggest framework programs to assist decision makers on implementation of the NIP. Methods: Following analysis of the disease burden and economics of the five VPDs by the core team and Korean Advisory Committee on Immunization Practices sub-committee members, a Delphi survey was administered to 94 Korean experts using structured questionnaires that provided the reference data. The two evaluation frameworks for NIP prioritization were (1) a disease-related framework and (2) a vaccine-related framework. After analyzing the responses, a meeting of experts was held to build a consensus for determining how to prioritize NIP implementation. Results: The average scores for relative importance were 63.29 for the disease-related framework and 36.71 for the vaccine-related framework. Within the disease-related framework, the mortality and case fatality rate was the highest scored factor (8.97), whereas within the vaccine-related framework, efficacy of the vaccine was considered the most important factor (9.56). On average, Spn, Hib, and HepA had the highest priority scores. Conclusion: The Korean experts suggested that the main factors influencing the decision to adopt new vaccines in the Korean NIP should be disease mortality, case fatality, and the efficacy and effectiveness of the vaccine. Among the five selected VPDs, Spn, Hib, and HepA were considered to be of higher priority than RV and HPV. (C) 2014 Elsevier Ltd. All rights reserved. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER SCI LTD | - |
dc.subject | POLICY | - |
dc.subject | IMPLEMENTATION | - |
dc.subject | CHILDREN | - |
dc.title | Prioritization of the introduction of new vaccines to the national immunization program in the Republic of Korea | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Chun, Byung-Chul | - |
dc.identifier.doi | 10.1016/j.vaccine.2014.09.009 | - |
dc.identifier.scopusid | 2-s2.0-84907996748 | - |
dc.identifier.wosid | 000343845300005 | - |
dc.identifier.bibliographicCitation | VACCINE, v.32, no.46, pp.6049 - 6053 | - |
dc.relation.isPartOf | VACCINE | - |
dc.citation.title | VACCINE | - |
dc.citation.volume | 32 | - |
dc.citation.number | 46 | - |
dc.citation.startPage | 6049 | - |
dc.citation.endPage | 6053 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Immunology | - |
dc.relation.journalResearchArea | Research & Experimental Medicine | - |
dc.relation.journalWebOfScienceCategory | Immunology | - |
dc.relation.journalWebOfScienceCategory | Medicine, Research & Experimental | - |
dc.subject.keywordPlus | POLICY | - |
dc.subject.keywordPlus | IMPLEMENTATION | - |
dc.subject.keywordPlus | CHILDREN | - |
dc.subject.keywordAuthor | National Immunization Program | - |
dc.subject.keywordAuthor | Priority | - |
dc.subject.keywordAuthor | Delphi survey | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.